FRANKLIN RESOURCES INC

Position in EBS — Emergent BioSolutions Inc.

CIK 38777 San Mateo, CA

Position in EBS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,398,144

+$54,018 QoQ

Shares Held

166,843

+3.0% QoQ

Ownership

0.325%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#41

of 194 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. EBS ranks #19 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	340,275	$184,371,197
2	INDV	Indivior Pharmaceuticals, Inc.	3,316,358	$136,070,166
3	NBIX	Neurocrine Biosciences Inc	553,068	$93,214,076
4	VTRS	Viatris Inc	5,658,439	$89,856,006
5	ZTS	Zoetis Inc.	912,367	$65,562,688
6	ALKS	Alkermes plc.	1,170,242	$61,320,679
7	AMLX	Amylyx Pharmaceuticals, Inc.	2,950,225	$52,986,040
8	RDY	Dr Reddys Laboratories Ltd	2,844,583	$41,218,006

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,398,144	166,843	+3.0%	Shares	Defined	2026-08-13
2026-03-31	$1,344,126	161,943	+105.1%	Shares	Defined	2026-05-13
2025-12-31	$975,760	78,945	+2.3%	Shares	Defined	2026-02-11
2025-09-30	$680,736	77,181	+1725.9%	Shares	Defined	2025-11-13
2021-09-30	$211,644	4,227	-94.6%	Shares	Defined	2021-11-12
2021-06-30	$4,918,194	78,079	-82.4%	Shares	Defined	2021-08-13
2021-03-31	$41,155,597	442,962	+0.6%	Shares	Defined	2021-05-13
2020-12-31	$39,434,482	440,117	+8.0%	Shares	Defined	2021-02-10
2020-09-30	$42,112,760	407,556	+0.1%	Shares	Defined	2020-11-12
2020-06-30	$32,192,597	407,089	-0.2%	Shares	Defined	2020-08-13
2020-03-31	$23,605,317	407,973	—	Shares	Defined	2020-05-13
No filing history on record for this holder in this stock.